000 | 01514 a2200433 4500 | ||
---|---|---|---|
005 | 20250514000748.0 | ||
264 | 0 | _c20010614 | |
008 | 200106s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, N | |
245 | 0 | 0 |
_aSuppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. _h[electronic resource] |
260 |
_bCancer research _cMay 2001 |
||
300 |
_a3908-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarcinogens _xantagonists & inhibitors |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xchemically induced |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xchemically induced |
650 | 0 | 4 |
_aDNA _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMitogen-Activated Protein Kinase 9 |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xdeficiency |
650 | 0 | 4 |
_aPapilloma _xchemically induced |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aSkin Neoplasms _xchemically induced |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xantagonists & inhibitors |
650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
700 | 1 | _aNomura, M | |
700 | 1 | _aShe, Q B | |
700 | 1 | _aMa, W Y | |
700 | 1 | _aBode, A M | |
700 | 1 | _aWang, L | |
700 | 1 | _aFlavell, R A | |
700 | 1 | _aDong, Z | |
773 | 0 |
_tCancer research _gvol. 61 _gno. 10 _gp. 3908-12 |
|
999 |
_c11290883 _d11290883 |